Expanding Reproductive Genetic Health Space to Drive Growth of the Hereditary Testing Market

In the past, there was limited awareness about reproductive health, especially about genetic health. Reproductive genetic health is evolving rapidly, creating awareness and new opportunities in the hereditary testing market. Family planning and demand for genetic insights continue to rise as awareness increases and individuals seek more information about this. The accessibility and affordability are improving. Genetic testing is recommended in the earlier stage of the reproductive journey for better preparedness. As advancement continues, the market for hereditary testing is positioned for significant expansion.

In this blog post, we cover what reproductive genetic health and hereditary testing are. We also shed light on technological advancements shaping the hereditary testing space.

Reproductive Genetic Health: Overview

Reproductive health is primarily influenced by genetic factors, and the reproductive genetic health space focuses on the same. By including testing methods and tools, it identifies inherited risks during or before pregnancy, as well as genetic factors. By using this health space, individuals can get guidance regarding medical decisions and preventive care for early genetic conditions. This space also encourages early screening for improvement of long-term health outcomes for future generations, supporting healthy pregnancies and reducing the risk of infertility and hereditary disorders. As the demand for personalized healthcare is increasing, this space is gaining more attention and becoming an important part of reproductive planning. As awareness is increasing, this space is becoming a key part of modern reproductive healthcare.

Hereditary Testing Explained

Genes are passed from one generation to another, forming genetic variation. In hereditary testing, genes and their variations are the main focus. It determines health risks, disorders, or certain conditions a person has inherited. Hereditary testing supports early detection, preventive care, and decision-making.

The hereditary testing market is growing as awareness about reproductive genetic health is rising. The market for hereditary testing stood at USD 7.73 billion in 2024 and is anticipated to reach USD 17.13 billion by 2034. The projected compound annual growth rate (CAGR) from 2025 to 2034 is 8.3%.

Technological Advancements Shaping Hereditary Testing

With advancements in reproductive genetics and modern technology, reproductive planning, healthier pregnancy outcomes, early detection of inherited disorders, and identification of genetic risks have been improved.

Next Generation Sequencing (NGS): Traditionally, in sequencing methods, only one DNA segment could be processed at a time. But with the next generation sequencing market, millions of DNA fragments can be processed simultaneously. NGS is an advanced technology that analyzes DNA at high speed and in large volumes. It supports carrier screening, prenatal testing, and embryo testing in IVF during the reproductive process. With the help of NGS measurements, early diagnosis, personalized care, and medical decision-making are significantly improved.

Non-Invasive Prenatal Testing (NIPT): A method to screen for genetic disorders that is done in early pregnancy without having to put the mother through any invasive procedures. Some of the Chromosomal Abnormalities that can be identified with NIPT include Trisomy 18 (Edwards Syndrome), Trisomy 13 (Patau Syndrome), and Down Syndrome. For NIPT, the mother provides a blood sample that contains fragments of fetal DNA for the purpose of screening. In other words, NIPT is a popular option for reproductive genetic health care for the majority of mothers who are interested in non-invasive prenatal testing methods. NIPT solutions from the non-invasive prenatal testing market are widely preferred in reproductive genetic healthcare.

Pre-implantation Genetic Testing (PGT): A type of testing used during In Vitro Fertilization (IVF) to evaluate embryos before implantation. PGT tests for genetic abnormalities, chromosomal abnormalities, and inherited diseases to help identify healthier embryos before they are implanted into the mother's uterus. The use of PGT can help reduce the chance of passing hereditary diseases to the baby while increasing the chance of having a healthy pregnancy.

Artificial Intelligence and Machine Learning (AI/ML): With large amounts of data and data-driven insights, the detection of inherited disorders becomes more accurate and efficient. AI and ML are used in analyzing large-scale genetic data with improved speed and accuracy. These help identify patterns, predict genetic risk, and support clinical decision-making. As these technologies continue to develop, they are improving access to the hereditary testing market.

Conclusion

The combination of innovations and increasing awareness among patients and healthcare professionals is a driving force in reproductive genetics health. Technological advancements will continue to enhance our ability to detect disorders at an earlier stage, provide personalized care for patients, and create ways to facilitate the patient and couple's reproductive plan, as we gain new insight into the hereditary nature of many disorders. As the focus on reproductive genetic health continues to grow, it is anticipated that hereditary testing will become one of the main aspects of modern tools for genetic testing, which can support a healthier pregnancy outcome and minimize the risk of heritable disorders.